-
公开(公告)号：EP2136782B1
公开(公告)日：2013-06-05
申请号：EP08749111.4
申请日：2008-04-24
申请人： Azad Pharma AG
CPC分类号： A61K9/0048 , A61K9/107 , A61K31/557 , A61K31/5575 , A61K47/14 , A61K47/26 , A61K47/44 , Y02A50/465
摘要： The present invention refers to an oil-in-water emulsion for ophthalmic application comprising at least one prostaglandin as active agent and a surfactant component comprising a combination of at least two non-ionic surfactants. The emulsion is suitable for medical applications, particularly for the treatment of glaucoma, and has an increased chemical stability of the prostaglandin active agent so to allow long-term storage also at room temperature.
-
公开(公告)号：EP3593862A1
公开(公告)日：2020-01-15
申请号：EP18183127.2
申请日：2018-07-12
申请人： Azad Pharma AG
摘要： The present application refers to an electrochemically activated salt solution (ECAS), its production, and its use for treating infections.
-
公开(公告)号：EP2136782A1
公开(公告)日：2009-12-30
申请号：EP08749111.4
申请日：2008-04-24
申请人： Azad Pharma AG
IPC分类号： A61K9/00 , A61K47/10 , A61K47/26 , A61K31/557 , A61K47/44
CPC分类号： A61K9/0048 , A61K9/107 , A61K31/557 , A61K31/5575 , A61K47/14 , A61K47/26 , A61K47/44 , Y02A50/465
摘要： The present invention refers to an oil-in-water emulsion for ophthalmic application comprising at least one prostaglandin as active agent and a surfactant component comprising a combination of at least two non-ionic surfactants. The emulsion is suitable for medical applications, particularly for the treatment of glaucoma, and has an increased chemical stability of the prostaglandin active agent so to allow long-term storage also at room temperature.
-
-
5.发明授权
公开(公告)号：EP2178501B1
公开(公告)日：2018-05-02
申请号：EP08801496.4
申请日：2008-07-28
申请人： Azad Pharma AG
发明人： BARONIAN, Mihran
CPC分类号： A61K9/0048 , A61K9/0043 , A61L12/08 , A61L12/10 , A61L12/107 , C11D3/0078 , C11D3/3956 , C11D11/007
摘要： The present application refers to pharmaceutical preparations comprising an active ingredient and a carrier wherein the carrier comprises an aqueous electrochemically activated salt solution.
-
公开(公告)号：EP3919047A1
公开(公告)日：2021-12-08
申请号：EP20178029.3
申请日：2020-06-03
申请人： AZAD Pharma AG
IPC分类号： A61K9/00 , A61K9/107 , A61K47/02 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/36 , A61P27/04
摘要： The present invention refers to a microemulsion, particularly suitable for ophthalmic applications such as treatment of dry eye syndrome, which comprises at least one oily component, an aqueous phase, at least one non-ionic surfactant, at least one polysaccharide, a salt or a derivative thereof, and at least one cross-linking agent. Moreover, the present invention relates to a process of manufacturing a microemulsion according to the invention, as well as its use in ophthalmic applications or as a carrier.
-
-
8.发明授权PHARMACEUTICAL MICROEMULSION FOR PREVENTING SUPRAMOLECULAR AGGREGATION OF AMPHIPHILIC MOLECULES 有权PHARMACEUTICAL微乳液预防两亲分子的超分子聚集的
公开(公告)号：EP2384188B1
公开(公告)日：2013-05-15
申请号：EP10700049.9
申请日：2010-01-05
申请人： Azad Pharma AG
CPC分类号： A61K9/0019 , A61K9/1075 , A61K31/337 , A61K47/10 , A61K47/14 , A61K47/26 , A61K47/44
-
9.发明公开PHARMACEUTICAL MICROEMULSION FOR PREVENTING SUPRAMOLECULAR AGGREGATION OF AMPHIPHILIC MOLECULES 有权PHARMACEUTICAL微乳液预防两亲分子的超分子聚集的
公开(公告)号：EP2384188A1
公开(公告)日：2011-11-09
申请号：EP10700049.9
申请日：2010-01-05
申请人： Azad Pharma AG
CPC分类号： A61K9/0019 , A61K9/1075 , A61K31/337 , A61K47/10 , A61K47/14 , A61K47/26 , A61K47/44
摘要： The present invention refers to a microemulsion formulation suitable for preventing assembly of amphiphilic drug molecules which may cause hypersensitivity reactions and other unwanted side effects.
-
10.发明公开
公开(公告)号：EP2178501A2
公开(公告)日：2010-04-28
申请号：EP08801496.4
申请日：2008-07-28
申请人： Azad Pharma AG
发明人： BARONIAN, Mihran
CPC分类号： A61K9/0048 , A61K9/0043 , A61L12/08 , A61L12/10 , A61L12/107 , C11D3/0078 , C11D3/3956 , C11D11/007
摘要： The present application refers to pharmaceutical preparations comprising an active ingredient and a carrier wherein the carrier comprises an aqueous electrochemically activated salt solution.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.014 秒)
